Recent FDA Announcement Implies There Will Be No Further Clamping Down On CBD Than It Already Has Done
The cannabis industry tripled revenue between 2014 and 2018 and now is all set to see a 400% increase by 2030. However, there’s expected to be an even faster-growing niche within the cannabis movement that’s drawn a lot of attention from investors. I’m talking about cannabidiol (CBD). Cannabidiol is basically the nonpsychoactive cannabinoid developed from hemp that is known for its medical values. It is more popular than CBD-based products, mainly because the latter tends to have THC, a component responsible for getting users high. From all aspects, CBD could be the next big investment, but the FDA is still working on reviewing it to make sure it is safe.
Charlotte’s Web is one of the biggest in the CBD space, but lately, the company has seen its sales dwindling – mainly due to the issues related to FDA’s statements on CBD. However, recently, the FDA announced that it would not be imposing any more rules on CBD than there already is, offering some good news. While the CBD industry is not going to go down any time soon, we cannot also expect the FDA to lay down concrete rules anytime soon either.
The one potential issue that CBD companies will continue to navigate is ensuring that they properly advertise their products and don’t make any unsubstantiated claims.
Read Full Article: https://www.fool.com
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.